Currently out of the existing stock ratings of Matthew Gillmor, 6 are a HOLD (10.17%), 53 are a BUY (89.83%).

Matthew Gillmor

Work Performance Price Targets & Ratings Chart

Analyst Matthew Gillmor, currently employed carries an average stock price target met ratio of 89.44% that have a potential upside of 22.49% achieved within 235 days. Previously, Matthew Gillmor worked at BAIRD.

Matthew Gillmor’s has documented 133 price targets and ratings displayed on 10 stocks. The coverage was on Healthcare, Technology sectors.

Most recent stock forecast was given on ACCD, Accolade at 15-Jan-2021.

Wall Street Analyst Matthew Gillmor

Analyst best performing recommendations are on TDOC (TELADOC).
The best stock recommendation documented was for TDOC (TELADOC) at 2/27/2020. The price target of $130 was fulfilled within 1 day with a profit of $5.15 (3.81%) receiving and performance score of 38.11.

Average potential price target upside

of $13.43 (17.61%) on TDOC (TELADOC).
of $29.57 (27.23%) on ATHN (ATHENAHEALTH).
of $12.02 (18.85%) on CERN (CERNER CORP).

ACCD Accolade ADUS Addus HomeCare EVH Evolent Health TDOC Teladoc TRHC Tabula Rasa HealthCare VCRA Vocera Communications CERN Cerner Corp ATHN athenahealth HSTM HealthStream RCM R1 RCM

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Ricky Goldwasser (MORGAN STANLEY)